We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Biomarkers Show Highest Risk for Testicular Cancer

By LabMedica International staff writers
Posted on 19 Jun 2017
Results of a large genome-wide association study (GWAS) have enabled the identification of 19 new risk loci and potential regulatory mechanisms influencing the susceptibility to testicular germ cell cancer.

Genome-wide association studies have transformed understanding of susceptibility to testicular germ cell tumors (TGCTs), but much of the heritability has remained unexplained. To clarify this topic, investigators at The Institute of Cancer Research, London (United Kingdom) conducted a new GWAS - a meta-analysis combined with previous GWAS and a replication series, totaling 7,319 TGCT cases and 23,082 controls.

The investigators reported the identification of 19 new TGCT risk loci, roughly doubling the number of known TGCT risk loci to 44. By performing in situ Hi-C (a chromosome conformation capture technique) in TGCT cells, they provided evidence for a network of physical interactions among all 44 TGCT risk SNPs (single-nucleotide polymorphism) and candidate causal genes.

These results allowed the investigators to select the 1% of men at highest risk of developing the disease. These men had a 7% lifetime risk of developing testicular cancer - a risk 14 times higher than the 0.5% risk in the general male population.

Senior author Dr. Clare Turnbull, senior researcher in genetics and epidemiology at The Institute of Cancer Research, London, said, "Our study has almost doubled the number of DNA variations linked to increased risk of developing testicular cancer and advanced our ability to use genetics to predict disease in healthy men. Although we are making good headway, there are more genetic changes that affect risk still to be found. Further studies are needed to understand how these genetic changes interact over time to influence the biology of the cell and lead to development of cancer."

The study was published in the June 12, 2017, online edition of the journal Nature Genetics.

Related Links:
The Institute of Cancer Research

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Latest Molecular Diagnostics News

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Fluid Biomarker Test Detects Neurodegenerative Diseases Before Symptoms Appear